Jacob Waugh, Chief Scientific Officer at Revance Therapeutics, Inc. (RVNC), sold 25,000 shares at $24.47 ($612K) on 2014-08-18, disclosed to the SEC on 2014-08-20.
Open-market sale of $612k RVNC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.